# Phio Pharmaceuticals Corp.: Form 10-K for the period ended Dec 31, 2016

- Company: [Phio Pharmaceuticals Corp.](/companies/phio.md) (CIK 1533040)
- Form: 10-K
- Filed: 2017-03-30
- Accepted by EDGAR: Mar 30, 2017, 07:01 ET
- Period: 2016-12-31
- Accession: 0001193125-17-102730
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1533040/000119312517102730/d325199d10k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1533040/000119312517102730/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2016-12-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 12 months, 2016-01-01 to 2016-12-31 | $19.0k | us-gaap:Revenues |
| Research and development | 12 months, 2016-01-01 to 2016-12-31 | $5.4m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 12 months, 2016-01-01 to 2016-12-31 | −$9.0m | us-gaap:OperatingIncomeLoss |
| Income tax | 12 months, 2016-01-01 to 2016-12-31 | $0 | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months, 2016-01-01 to 2016-12-31 | −$9.0m | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months, 2016-01-01 to 2016-12-31 | −$1.64 | us-gaap:EarningsPerShareBasicAndDiluted |
| Operating cash flow | 12 months, 2016-01-01 to 2016-12-31 | −$7.8m | us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations |
| Capital expenditure | 12 months, 2016-01-01 to 2016-12-31 | $4.0k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | at 2016-12-31 | $12.9m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2016-12-31 | $13.1m | us-gaap:AssetsCurrent |
| Total assets | at 2016-12-31 | $13.4m | us-gaap:Assets |
| Current liabilities | at 2016-12-31 | $2.5m | us-gaap:LiabilitiesCurrent |
| Shareholders' equity | at 2016-12-31 | $10.9m | us-gaap:StockholdersEquity |

## Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/1533040/000119312517102730/d325199d10k.htm

Filed Mar 30, 2017.
Source: SEC EDGAR, the filing index for accession 0001193125-17-102730. Last ingested by Listed: Nov 12, 2026, 20:44 ET. No prices; not investment advice.
